However, the difference in weight loss effect of GLP-1RAs between the two BMI groups was insignificant
Glucagon receptor activation increases hepatic fat oxidation and raises resting energy expenditure
Temporary dose reduction during illness or significant life stress is reasonable, with resumption of escalation once circumstances normalize
During this period, people typically experience a more consistent reduction in appetite, leading to decreased calorie intake
Over the last decade, weve made meaningful progress around body neutrality, reducing weight stigma, and recognizing that health is about much more than a number on the scale, says Danielle Dow, LPC, a body image therapist at Mountain Top Counseling in Pennsylvania
There is evidence of people taking GLP-1 drugs reporting changes in their cravings for certain foods, like sweets